
LIMIS Development
Our vision
At LIMIS Development we aim to increase patient safety by improving the standard of care through technological breakthroughs. We strive for meaningful innovation that improves surgical outcomes with less complications for patients worldwide. We combine specialized medical research on specific medical and surgical needs in the field of perfusion imaging, to create innovative and sustainable new technologies and products for multiple applications.
Our mission
We work in close collaboration with clinicians, hospitals, industry and universities to ultimately help improve the quality of care. With PerfusiX-Imaging we want to assist surgeons by providing them with relevant information: visualizing tissue perfusion. Helping them make better decisions in their day-to-day practices. PerfusiX-Imaging is a platform technology (patents granted) designed for multiple clinical needs and was initially focused on colon surgery towards reduction of anastomotic leakage. More clinical applications and new product developments are ongoing.
LIMIS has a ESG-policy, underpinning that involving Environment, Social en Governance aspects are important to us in our way of working.
Our pathway
2000
Offering courses in laparoscopic colon surgery
2014
Start-up entity, seed funding for PerfusiX-Imaging
2016
First clinical trial on laparoscopic colon perfusion
2019
First funding round for Perfusix-Imaging
2021
(Pre-)clinical studies and prototype testing
2022
Patents on core technologies granted
2023
Product finalization and preparing for certification
Meet our team of specialists
Core Team
Managing Director and founder
Head Surgical Innovation
Clinical Researcher
R&D Engineer
Software Engineer
QA/RA manager
Research Engineer
Product & Operations Manager
Medical Specialists
Prof. dr. Jean-Pierre Pierie, MD
GI Surgeon
Prof. dr. Christiaan Boerma, MD
Perfusion Specialist
Christiaan Hoff, MD
GI Surgeon
Sietze Koopal, MD
GI Surgeon
Board
Managing Director and founder
Supervisory Board
Edwin Schulting, MSc
CEO and co-founder of IMDS-Interventional Medical Device Solutions
Chairman
Diederik Jongema
COO Investment company Bufr and experienced investment manager
LIMIS Development innovates